However, other myeloid-cell specific mechanisms must also be involved in the enhancement of the ATRA-dependent anti-proliferative effect afforded by S100A3 silencing, as indicated by the results obtained in PML-RARα− and AML-derived HL-60 cells. The gene discussed is S100A3; the disease is acute myeloid leukemia.